<?xml version="1.0" encoding="UTF-8"?>
<p>The efficacy of medicinal cannabinoids in reducing overall PTSD symptomatology might indeed find a possible explanation in their mechanism of action, given their modulatory influence on different neurotransmitter systems, as demonstrated by the presence of CB receptors in pre-synaptic GABAergic and glutamatergic terminations, but also in noradrenergic, serotoninergic, and dopaminergic axon terminals [
 <xref rid="B27-life-11-00214" ref-type="bibr">27</xref>,
 <xref rid="B60-life-11-00214" ref-type="bibr">60</xref>]. 
</p>
